These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 28403994)

  • 21. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis.
    Zhao Y; Zhu L; Yang Y; Gao H; Zhang R
    Acta Clin Belg; 2023 Jun; 78(3):234-244. PubMed ID: 35913111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed.
    Milling TJ; Spyropoulos AC
    Am J Emerg Med; 2016 Nov; 34(11S):19-25. PubMed ID: 27697440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    Shirai T; Yamamoto T; Kawasugi K; Kuyama Y; Kita H
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):841-846. PubMed ID: 27569738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
    Radadiya D; Devani K; Brahmbhatt B; Reddy C
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e50-e58. PubMed ID: 33470705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct oral anticoagulant drugs (DOAC).
    Blum RA; Lindfield D
    J Cataract Refract Surg; 2016 Jan; 42(1):171-2. PubMed ID: 26948793
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experience.
    Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Spurr C; Sridhar S
    Korean J Gastroenterol; 2015 Apr; 65(4):205-14. PubMed ID: 25896154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis.
    Lapumnuaypol K; DiMaria C; Chiasakul T
    QJM; 2019 Aug; 112(8):605-610. PubMed ID: 31135040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What gastroenterologists should know about direct oral anticoagulants.
    Radaelli F; Fuccio L; Paggi S; Bono CD; Dumonceau JM; Dentali F
    Dig Liver Dis; 2020 Oct; 52(10):1115-1125. PubMed ID: 32532603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
    Bundhun PK; Soogund MZ; Teeluck AR; Pursun M; Bhurtu A; Huang WQ
    BMC Cardiovasc Disord; 2017 Jan; 17(1):15. PubMed ID: 28056795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.
    Sivolella S; De Biagi M; Brunello G; Berengo M; Pengo V
    Odontology; 2015 Sep; 103(3):258-63. PubMed ID: 25656043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse Drug Reactions and Cutaneous Manifestations Associated With Anticoagulation.
    Vu TT; Gooderham M
    J Cutan Med Surg; 2017; 21(6):540-550. PubMed ID: 28639463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European guidelines on perioperative venous thromboembolism prophylaxis: Patients with preexisting coagulation disorders and after severe perioperative bleeding.
    Ahmed A; Kozek-Langenecker S; Mullier F; Pavord S; Hermans C;
    Eur J Anaesthesiol; 2018 Feb; 35(2):96-107. PubMed ID: 29112549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.